In successful antiviral therapy of hepatitis B, drug combinations, particularly combinations without cross-resistance, can delay or prevent the emergence of drug-resistant mutants. Because drug-resistant mutants are archived and may limit future therapeutic options, prevention is important for long-
β¦ LIBER β¦
Combination therapy: the risks of infection and tumor induction
β Scribed by Yocum, David E.
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 635 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0344-4325
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Benefits and risks of combination therap
β
Norah A. Terrault
π
Article
π
2009
π
John Wiley and Sons
π
English
β 102 KB
Antiβtumor necrosis factor Ξ± therapy and
β
Jonathan C. P. Roos; Andrew J. K. Ostor
π
Article
π
2005
π
John Wiley and Sons
π
English
β 57 KB
π 1 views
Modeling of tumor growth and anticancer
β
Gilbert Koch; Antje Walz; Gezim Lahu; Johannes Schropp
π
Article
π
2009
π
Springer
π
English
β 360 KB
Tumor necrosis factor inhibitor therapy
β
Giles, Jon T. ;Bartlett, Susan J. ;Gelber, Allan C. ;Nanda, Shikha ;Fontaine, Ke
π
Article
π
2006
π
John Wiley and Sons
π
English
β 81 KB
π 2 views
Early infection and risk of childhood br
β
Amanda K. Shaw; Peizhi Li; Claire Infante-Rivard
π
Article
π
2006
π
Springer Netherlands
π
English
β 125 KB
The risks and benefits of drug therapy
β
George Destevens
π
Article
π
1987
π
John Wiley and Sons
π
English
β 609 KB
There is no such thing as an absolutely safe drug. There never was, and I doubt that there will ever be one. Considering this opening statement, I would like to take you through an historical trip on the evolution of drug therapy, what the risks and benefits are, and what the new era of biotechnolog